Buffalo, NY, United States of America

Candace Johnson

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Centro De Inmunologia Molecular, Innovative Immunotherapy Alliance, S.A.. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Candace Johnson: Innovator in Therapeutic Compositions

Introduction

Candace Johnson is a notable inventor based in Buffalo, NY (US). He has made significant contributions to the field of therapeutic compositions, particularly in the treatment of tumors of epithelial origin. His innovative work has led to the development of a patent that addresses critical medical challenges.

Latest Patents

Candace Johnson holds a patent titled "Use of Therapeutic Compositions for the Treatment of Patients with Tumors of Epithelial Origin." This patent represents a significant advancement in cancer treatment, showcasing his commitment to improving patient outcomes through innovative solutions. He has 1 patent to his name.

Career Highlights

Throughout his career, Johnson has worked with various organizations that focus on immunotherapy and cancer research. Notably, he has been associated with Innovative Immunotherapy Alliance, S.A. and Centro De Inmunologia Molecular. His work in these companies has contributed to the advancement of therapeutic strategies in oncology.

Collaborations

Johnson has collaborated with Tania Crombet Ramos, a fellow professional in the field. Their partnership has likely fostered innovative ideas and approaches to cancer treatment, enhancing the impact of their work.

Conclusion

Candace Johnson's contributions to the field of therapeutic compositions highlight his dedication to advancing medical science. His patent and collaborations reflect a commitment to improving treatment options for patients with tumors of epithelial origin.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…